New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease
Currently, combinations of long-acting beta2-agonists and long-acting anticholinergics are considered as the basic therapy for majority of patients with chronic obstructive pulmonary disease (COPD). These combinations have different pharmacological characteristics and delivery devices that provides...
Main Authors: | S N Avdeev, N V Trushenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2019-03-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/33018/pdf |
Similar Items
-
12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review
by: A. A. Vizel, et al.
Published: (2018-10-01) -
Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment
by: Shih-Lung Cheng
Published: (2021-06-01) -
Modern possibilities of correction of broncho-obstructive syndrome in chronic heart failure of ischemic origin in combination with chronic obstructive pulmonary disease: simple randomized parallel group study
by: Vladimir V. Evdokimov, et al.
Published: (2023-06-01) -
The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants
by: Li W, et al.
Published: (2023-11-01) -
Clinical experience of using formoterol/budesonide in patients with chronic obstructive pulmonary disease
by: I. V. Demko, et al.
Published: (2021-10-01)